-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene Therapeutics Q4 EPS $(0.17) Beats $(0.22) Estimate

Benzinga·03/12/2026 20:03:10
Listen to the news
Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.22) by 21.66 percent. This is a 39.29 percent increase over losses of $(0.28) per share from the same period last year.